To determine the effect of altered BRD7 expression on aerobic glycolysis in breast cancer cells, overexpression experiment of BRD7 were performed in HER2-negative MCF-7 and MDA-MB-231 cells and HER2-positive MDA-MB-453 cells. Here, ERBB2 is linked to breast cancer.